• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Letitia James.
    Healthcare

    Johnson & Johnson reaches $230 million settlement with New York to end opioid business

    Carly Roman -
    June 26, 2021 8:01 pm
    0
    EXCLUSIVE - Bill Maher speaks on stage at the 2014 Television Academy Hall of Fame on Tuesday, March 11, 2014, at the Beverly Wilshire in Beverly Hills, Calif.
    Healthcare

    Bill Maher blasts Big Tech for blocking Wuhan lab leak theory: ‘You were wrong!’

    Lawrence Richard -
    June 26, 2021 6:32 pm
    0
    U.S. deterrence policy has generated plenty of criticism from Capitol Hill. But that has been aimed at the administration's supposedly narrow view of what constitutes an attack and unwillingness to spell out likely responses.
    Healthcare

    Controversial Alzheimer’s drug a godsend for a trial participant, but price tag could put it out of reach

    Cassidy Morrison -
    June 25, 2021 3:00 am
    0
    Liberal watchdog group pushes FDA leadership to resign over controversial Alzheimer’s treatment approval
    Healthcare

    Liberal watchdog group pushes FDA leadership to resign over controversial Alzheimer’s treatment approval

    Cassidy Morrison -
    June 17, 2021 3:36 pm
    0
    Three members of FDA drug review panel resign over approval of $56K Alzheimer’s drug
    Healthcare

    Three members of FDA drug review panel resign over approval of $56K Alzheimer’s drug

    Cassidy Morrison -
    June 11, 2021 2:59 pm
    0
    Moderna requests FDA authorization to give adolescents COVID-19 vaccine
    Healthcare

    Moderna requests FDA authorization to give adolescents COVID-19 vaccine

    Cassidy Morrison -
    June 10, 2021 1:55 pm
    0
    U.S. deterrence policy has generated plenty of criticism from Capitol Hill. But that has been aimed at the administration's supposedly narrow view of what constitutes an attack and unwillingness to spell out likely responses.
    Healthcare

    Medicare Part D benefit design leads to higher costs for specialty drugs

    David Hogberg -
    June 4, 2021 3:00 am
    0
    In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. As Congress and the Trump administration aim to curb spiraling drug costs, outside groups like the Alliance for Patient Access are raising their voices as they seek to sway the outcome.
    Healthcare

    Obamacare fans press Biden to OK controversial price negotiation

    Cassidy Morrison -
    May 28, 2021 11:00 am
    0
    Narsoplimab holds promise as treatment for severe COVID-19
    Healthcare

    Narsoplimab holds promise as treatment for severe COVID-19

    David Hogberg -
    May 25, 2021 3:19 pm
    0
    U.S. deterrence policy has generated plenty of criticism from Capitol Hill. But that has been aimed at the administration's supposedly narrow view of what constitutes an attack and unwillingness to spell out likely responses.
    Business

    Congress takes aim again at pharmaceutical giant over patent-stacking for brand-name drugs

    Cassidy Morrison -
    May 21, 2021 3:00 am
    0
    1...434445...159Page 44 of 159
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.